Lusutrombopag
Lusutrombopag is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Mulpleta. Available dosage forms: tablet, film coated, powder.
Drug Details
- Generic Name
- Lusutrombopag
- Brand Names
- Mulpleta
- Application Number
- NDA210923
- Sponsor
- SHIONOGI INC.
- NDC Codes
- 4
- Dosage Forms
- TABLET, FILM COATED, POWDER
- Routes
- ORAL
- Active Ingredients
- LUSUTROMBOPAG
Indications and Usage
1 INDICATIONS AND USAGE MULPLETA is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. MULPLETA is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. ( 1 )